GeneBioTech Co. ,Ltd (KOSDAQ:086060)
4,780.00
-35.00 (-0.73%)
At close: Apr 28, 2026
GeneBioTech Co. ,Ltd Market Cap
GeneBioTech Co. ,Ltd has a market cap or net worth of 40.17 billion as of April 29, 2026. Its market cap has increased by 53.20% in one year.
Market Cap
40.17B
Enterprise Value
30.23B
Revenue
90.79B
Ranking
n/a
PE Ratio
10.60
Stock Price
4,780.00
Market Cap Chart
Since April 28, 2006, GeneBioTech Co. ,Ltd's market cap has increased from 35.91B to 40.17B, an increase of 11.85%. That is a compound annual growth rate of 0.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 35.06B |
| Korean Drug | 46.32B |
| HLscience | 46.75B |
| Seoul Pharma | 33.17B |
| Eagle Veterinary Technology Co.,Ltd | 50.88B |
| RP Bio | 54.16B |
| ChoA Pharmaceutical Co., LTD. | 29.52B |
| Korea Arlico Pharm | 56.10B |